Pancreatic neuroendocrine neoplasms

Last updated: November 01, 2022

Pancreatic neuroendocrine neoplasms

Endocrine system - ETP

Endocrine system - ETP

Pharyngeal arches, pouches, and clefts
Endocrine system anatomy and physiology
Anatomy of the thyroid and parathyroid glands
Anatomy of the abdominal viscera: Pancreas and spleen
Pituitary gland histology
Thyroid and parathyroid gland histology
Pancreas histology
Adrenal gland histology
Synthesis of adrenocortical hormones
Adrenocorticotropic hormone
Growth hormone and somatostatin
Hunger and satiety
Antidiuretic hormone
Thyroid hormones
Insulin
Insulins
Glucagon
Somatostatin
Cortisol
Testosterone
Estrogen and progesterone
Oxytocin and prolactin
Parathyroid hormone
Calcitonin
Vitamin D
Phosphate, calcium and magnesium homeostasis
Congenital adrenal hyperplasia
Adrenal insufficiency: Pathology review
Primary adrenal insufficiency
Waterhouse-Friderichsen syndrome
Hyperaldosteronism
Cushing syndrome and Cushing disease: Pathology review
Cushing syndrome
Conn syndrome
Pheochromocytoma
Adrenal masses: Pathology review
Adrenal masses and tumors: Clinical
Adrenal cortical carcinoma
Thyroglossal duct cyst
Hyperthyroidism
Hyperthyroidism: Pathology review
Graves disease
Thyroid eye disease (NORD)
Toxic multinodular goiter
Euthyroid sick syndrome
Hypothyroidism
Hypothyroidism: Pathology review
Hashimoto thyroiditis
Hypothyroidism and thyroiditis: Clinical
Subacute granulomatous thyroiditis
Riedel thyroiditis
Thyroid storm
Thyroid nodules and thyroid cancer: Pathology review
Thyroid cancer
Thyroid nodules and thyroid cancer: Clinical
Parathyroid disorders and calcium imbalance: Pathology review
Parathyroid conditions and calcium imbalance: Clinical
Hyperparathyroidism
Hypoparathyroidism
Hypercalcemia
Hypocalcemia
Diabetes mellitus
Diabetes mellitus: Pathology review
Diabetes mellitus: Clinical
Diabetic nephropathy
Diabetic retinopathy
Pancreatic neuroendocrine neoplasms
Diabetes insipidus and SIADH: Pathology review
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Hypopituitarism: Pathology review
Hypopituitarism
Hyperpituitarism
Pituitary adenoma
Pituitary apoplexy
Pituitary tumors: Pathology review
Sheehan syndrome
Hyperprolactinemia
Prolactinoma
Hypoprolactinemia
Gigantism
Acromegaly
Constitutional growth delay
Puberty and Tanner staging
Precocious puberty
Delayed puberty
Kallmann syndrome
Disorders of sex chromosomes: Pathology review
5-alpha-reductase deficiency
Menstrual cycle
Polycystic ovary syndrome
Premature ovarian failure
Menopause
Androgen insensitivity syndrome
Autoimmune polyglandular syndrome type 1 (NORD)
Multiple endocrine neoplasia: Pathology review
Multiple endocrine neoplasia
Carcinoid syndrome
Neuroblastoma
Opsoclonus myoclonus syndrome (NORD)
Hyperthyroidism medications
Hypothyroidism medications
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Mineralocorticoids and mineralocorticoid antagonists
Adrenal hormone synthesis inhibitors

Transcript

Watch video only

With pancreatic neuroendocrine neoplasms, neuroendocrine refers to pancreatic cells which release hormones in response to signals from the nerves, and neoplasm refers to a cancer.

So, pancreatic neuroendocrine neoplasm is a cancer of neuroendocrine cells that are within the pancreas.

They can also be called pancreatic neuroendocrine tumors, or just panNETs for short.

In addition to endocrine cells, the pancreas also has exocrine cells, which make up a majority of the gland.

Most pancreatic cancers arise from exocrine cells and they’re called adenocarcinomas, whereas only a minority arise from panNETs.

The pancreas is a long, skinny gland the length of a dollar bill which sits to the left of the duodenum and behind the stomach, in the upper abdomen, or the epigastric region.

It plays two main roles - there’s the exocrine part of the pancreas which has acinar cells that make digestive enzymes that are secreted into the duodenum to help digest food.

There’s also the endocrine part of the pancreas which has a few different types of islet cells, or neuroendocrine cells, each of which make different hormones.

These neuroendocrine cells are present in clusters, or islands, called islets of Langerhans.

The largest group of cells are the beta (β) cells which secrete insulin.

Insulin mainly lowers the blood glucose levels by transporting glucose into the cells, and also pushes potassium into cells, which decreases potassium in the blood.

Another group are the alpha (α) cells which secrete glucagon, a hormone that does exactly the opposite of insulin, it raises the blood glucose levels by getting the liver to generate glucose from amino acids and lipids, and to break down glycogen into glucose.

There are also Delta cells which secrete somatostatin, which decreases the release of other hormones, including insulin, glucagon, and serotonin.

There are also pancreatic polypeptide cells, which secrete pancreatic polypeptide, which stimulates the release of digestive enzymes from the stomach and small intestine, and slows down intestinal movement.

Finally, there are a few rare cell types called enterochromaffin cells, D1 cells, and G cells, which are scattered in the islets of Langerhans.

Enterochromaffin cells secrete serotonin, which helps with motility of the gastrointestinal tract.

D1 cells release a hormone, vasoactive intestinal polypeptide or VIP, which relaxes the small intestine and stimulates the release of intestinal digestive enzymes, but inhibits hydrochloric acid release from the stomach.

G cells are found in the pancreas and stomach, and the secrete gastrin.

Gastrin stimulates the parietal cells in the stomach mucosa to secrete hydrochloric acid, and also stimulates the glands in the epithelial layer.

In pancreatic neuroendocrine neoplasms, one of the many types of neuroendocrine cells mutates and starts dividing uncontrollably, forming a tumor over time.

Sometimes the mutation is in a tumor suppressor gene like PTEN and MEN1.

Tumor suppressor genes usually regulate cell growth, so when they mutate, the result is uncontrolled cell growth.

Mutation of the MEN1 gene results in an inherited condition known as multiple endocrine neoplasia, or MEN, type I, where adenomas or malignant tumors form in the parathyroid gland, pituitary gland, and pancreas.

Some PanNETs are benign tumors which means that they don’t invade nearby tissues, whereas others are malignant tumors meaning that they do invade surrounding tissues and even metastasize or spread through the lymph to distant ones.

PanNETs are classified into functional tumors, which secrete hormones, and non-functional tumors, which don’t secrete any hormone.

Non-functional panNETs are more common, and they’re usually asymptomatic until they grow to a large size and metastasize to other organs like the liver.

Large tumors can compress surrounding structures, for example, a tumor might compress the common bile duct, leading to a backup bile and causing obstructive jaundice, which is when the skin turns yellow from the buildup of bilirubin in the tissues.

Key Takeaways

Pancreatic neuroendocrine Tumors (PNETs) are a type of tumor that arises in the endocrine tissue of the pancreas. These tumors include insulinomas, gastrinoma, glucagonoma, and VIPomas, and secrete hormones including insulin, gastrin, glucagon, and vasoactive intestinal peptide respectively. Symptoms of PNETs may include abdominal pain, weight loss, and changes in bowel habits. Treatment options may involve drugs like somatostatin and surgery.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "The Pathologic Classification of Neuroendocrine Tumors" Pancreas (2010)
  6. "Update on pancreatic neuroendocrine tumors" PubMed (2014)